Jetflag
Legendary Member
- Jul 17, 2020
- 3,097 Posts
- 2,493 Thanked
Except If that where the (sole) case , you'd think Pfizer, Johnson & Johnson et all would pull all their vaccin's from the market aswell no?Because, surprise surprise, there is no longer any demand and it is not financially viable. No conspiracy here.
Johnson et Johnson not too long ago even switched from a Conditional to a Standard marketing autorisation in the EU..
If the market were that saturated and demand so low, then that wouldn't make much sense wouldn't it? Or have JJ leapfrogged VectorVaccin tech to such a degree that they left AstraZeneca firmly in the dust within the span of a year?